TGAM
AURA icon

TBH Global Asset Management’s Aura Biosciences AURA Stock Holding History

TBH Global Asset Management’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$428K Hold
60,322
– – 0.08% 200
2026
Q1 		$404K Hold
60,322
– – 0.08% 194
2025
Q4 		$329K Hold
60,322
– – 0.05% 203
2025
Q3 		$373K Hold
60,322
– – 0.07% 197
2025
Q2 		$378K Hold
60,322
– – 0.08% 142
2025
Q1 		$353K Hold
60,322
– – 0.07% 149
2024
Q4 		$496K Hold
60,322
– – 0.12% 145
2024
Q3 		$537K Hold
60,322
– – 0.12% 149
2024
Q2 		$456K Hold
60,322
– – 0.1% 160
2024
Q1 		$474K Hold
60,322
– – 0.09% 162
2023
Q4 		$534K Buy
60,322
+27,225
+82% +$231K 0.11% 139
2023
Q3 		$297K Hold
33,097
– – 0.06% 209
2023
Q2 		$409K Hold
33,097
– – 0.08% 168
2023
Q1 		$307K Buy
+33,097
New +$344K 0.07% 179

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

TBH Global Asset Management's AURA Position: Q2 2026 in Review

TBH Global Asset Management held its Aura Biosciences (AURA) position steady in Q2 2026 at 60,322 shares worth $428K. The position accounts for 0.08% of the portfolio, ranked #200.

TBH Global Asset Management first reported a position in AURA in Q1 2023 and has held it in 14 quarters since. The position peaked at $537K in Q3 2024. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • TBH Global Asset Management held 60,322 shares of Aura Biosciences worth $428K as of Q2 2026.
  • TBH Global Asset Management left its Aura Biosciences share count unchanged in Q2 2026.
  • Aura Biosciences made up 0.08% of TBH Global Asset Management's portfolio in Q2 2026, its #200 holding.
  • TBH Global Asset Management first reported a position in Aura Biosciences in Q1 2023 and has held it in 14 quarters since.
  • TBH Global Asset Management's Aura Biosciences position peaked at $537K in Q3 2024.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on TBH Global Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.